Post-earnings recap
Reported
Thu, Feb 10, 2011
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
25%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Arrowhead Pharmaceuticals reported a slight loss in earnings per share but did not provide revenue figures. The stock reacted minimally, decreasing by 0.01%. Investors may be cautious due to the lack of guidance and detailed financial metrics.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.02 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management maintained a neutral tone during the call, emphasizing ongoing projects. There was no specific guidance provided for future performance.
Management did not provide specific guidance for the upcoming quarters.
The earnings call focused on ongoing projects and research developments.